# Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®

> **NCT02191293** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 228 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Viramune® tablets

## Key facts

- **NCT ID:** NCT02191293
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2006-09
- **Final completion:** —
- **Target enrollment:** 228 (ACTUAL)
- **Last updated:** 2014-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02191293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02191293, "Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02191293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*